Skip to main content
ReproCELL Incorporated logo

ReproCELL Incorporated — Investor Relations & Filings

Ticker · 4978 ISIN · JP3974770004 LEI · 529900NM7KR32GGRSU46 T Professional, scientific and technical activities
Open in API
Filings indexed 62 across all filing types
Latest filing 2019-08-09 Interim / Quarterly Rep…
Country JP Japan
Listing T 4978

About ReproCELL Incorporated

https://www.reprocell.com/

ReproCELL Incorporated is a global company providing solutions for preclinical and clinical research, with a primary focus on stem cell technology, drug discovery, and regenerative medicine. The company's portfolio includes a wide range of products such as induced pluripotent stem cells (iPSCs), differentiated cells, 3D cell culture models, and specialized reagents like RNA-based reprogramming kits that avoid genomic integration. ReproCELL also offers extensive contract research services, including human tissue assays for evaluating drug efficacy and safety. A key area of expertise is the GMP-compliant manufacturing of clinical-grade iPSCs and iPSC-derived mesenchymal stem cells (iMSCs), supporting the development of advanced cell therapies. The company's tools and services are designed to help academic and commercial scientists accelerate the translation of research into clinical applications.

Recent filings

Filing Released Lang Actions
四半期報告書－第18期第1四半期(2019/04/01－2019/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for ReproCELL Incorporated, covering the first quarter of the 18th fiscal year (April 1, 2019, to June 30, 2019). It contains detailed financial statements, management analysis, and audit review information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2019-08-09 Japanese
有価証券報告書－第17期(平成30年4月1日－平成31年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It contains detailed financial statements, management indicators, and corporate information for the fiscal year ending March 31, 2019. It is not an announcement or a summary, but the full statutory annual filing submitted to the Kanto Local Finance Bureau. FY 2019
2019-06-28 Japanese
四半期報告書－第17期第3四半期(2018/10/01－2018/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the third quarter of the 17th fiscal period, filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet and income statement, and management analysis. It is a formal regulatory filing for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-02-13 Japanese
四半期報告書－第17期第2四半期(2018/07/01－2018/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for ReproCELL Incorporated, covering the second quarter of the 17th fiscal period (July 1, 2018, to September 30, 2018). It contains detailed financial statements, management analysis (MDA), and corporate information as required by the Financial Instruments and Exchange Act of Japan. Since it is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data, it is classified as an Interim/Quarterly Report (IR). H1 2019
2018-11-13 Japanese
四半期報告書－第17期第1四半期(2018/04/01－2018/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the first quarter of the 17th fiscal period (April 1, 2018 to June 30, 2018) for ReproCELL Incorporated. It contains detailed financial statements, management analysis (MDA), and business status updates, which are characteristic of an Interim/Quarterly Report. It is not an announcement of a report (RPA) as it contains the full content of the filing. Q1 2019
2018-08-10 Japanese
有価証券報告書－第16期(平成29年4月1日－平成30年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It contains comprehensive financial data, including consolidated and non-consolidated financial indicators, balance sheets, and business history for the fiscal year ending March 31, 2018. It is a formal regulatory filing submitted to the Kanto Local Finance Bureau. FY 2018
2018-06-25 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.